/NUS

NU Skin Enterprises Inc

NUS

$4.85USD↓-0.61%-0.03 today

MARKET CAP

236.1M

P/E (TTM)

4.5x

FWD P/E

—

DAY RANGE

$5 – $5

52W RANGE

$4

$15

AI Summary

Stalk

Sell NowMedium

The asset is firmly in a Stage 4 decline with dominant lower highs and lower lows, down-trending moving averages, and persistent distribution. Medium-term bias is bearish, supported by structural downtrend and bearish pattern implications. Short-term price has attempted a bounce but was rejected at falling EMAs, indicating execution readiness for selling. The long-term secular trend remains negative. Risks include possible oversold mean-reversion bounces and a reclaim of EMAs that could signal a reversal.

↑Dividend yield of 4.9% exceeds industry average, boosting income.
↑High earnings yield suggests attractive valuation versus peers.
↓Negative profitability metrics point to low margin conversion.

Full analysis →

Buying

2

institutions

Selling

6

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	4.32 M	22.79 M	+24.61 K	-27.1%	0.00%
RT Renaissance Technologies LLC Q2 2026	SELL	1.61 M	8.49 M	+-92.80 K	-31.4%	0.01%
AC Aqr Capital Management LLC Q2 2026	SELL	789.13 K	4.02 M	+-447.21 K	-54.7%	0.00%
CA Citadel Advisors LLC Q2 2026	BUY	684.88 K	3.62 M	+436.59 K	+100.1%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	142.59 K	751.44 K	+-64.71 K	-49.4%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	0.00	0.00	+-112.93 K	-100.0%	0.00%
MM Millennium Management LLC Q2 2026	SELL	0.00	0.00	+-110.14 K	-100.0%	0.00%
MG Man Group Plc Q2 2026	SELL	0.00	0.00	+-20.80 K	-100.0%	0.00%